Oral ulcerations in a patient with mantle cell lymphoma

Oral ulcerations in a patient with mantle cell lymphoma

Bibliographic Details
Main Authors:	Miranda Rosenberg, MD, Alyx Rosen Aigen, MD, Andrea Maderal, MD
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	International Journal of Women's Dermatology
Subjects:	Ibrutinib Aphthae Stomatitis Chemotherapy Mucositis Lymphoma
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352647520301192

Similar Items

Mantle Cell Lymphoma: Effectiveness of Maintenance Ibrutinib – Case Report
by: Danuta Krasowska, et al.
Published: (2020-09-01)

Viral Stomatitis
by: V.V. Mavrutenkov
Published: (2015-04-01)

Ibrutinib Is Effective in the Treatment of Autoimmune Haemolytic Anaemia in Mantle Cell Lymphoma
by: Aliénor Galinier, et al.
Published: (2017-01-01)

Cutaneous and Extracutaneous Manifestations of Behçet’s Disease Linked to Its Disease Activity and Prognosis
by: Limtong P, et al.
Published: (2020-08-01)

The Effect of Topical Sucralfate Suspension on Oral Aphthae
by: Z. Delavarian, et al.
Published: (2007-06-01)

Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)
by: Michael Wang, et al.
Published: (2017-11-01)

Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real‐world experience
by: Young‐Woo Jeon, et al.
Published: (2019-11-01)

Distinct BTK inhibitors differentially induce apoptosis but similarly suppress chemotaxis and lipid accumulation in mantle cell lymphoma
by: Zhuojun Liu, et al.
Published: (2021-06-01)

Management of Drug Resistance in Mantle Cell Lymphoma
by: Gaël Roué, et al.
Published: (2020-06-01)

Five year experience in ibrutinib therapy for relapsed and refractory mantle cell lymphoma in real world Russian clinical practice
by: Vladimir I. Vorobyev, et al.
Published: (2021-07-01)

Oral manifestations in human immunodeficiency virus infected patients
by: Sen Sumit, et al.
Published: (2010-01-01)

Estomatitis aftosa recurrente: Actualización RECURRENT APHTHOUS STOMATITIS: UPDATE
by: José A. Pacho Saavedra, et al.
Published: (2005-04-01)

Life-threatening disseminated enterovirus infection during combined rituximab and ibrutinib maintenance treatment for mantle cell lymphoma: a case report
by: Maximilian Higer, et al.
Published: (2020-08-01)

Intermediate Results of Prospective Observational Study: The 2-year Experience of Ibrutinib Therapy in Relapsed/Refractory Mantle Cell Lymphoma in Clinical Practice
by: VI Vorob’ev, et al.
Published: (2019-03-01)

Sustained Complete Remission in Multi-Relapsed Primary CNS Lymphoma Treated with Ibrutinib Monotherapy: A Case Report
by: Anna Mair, et al.
Published: (2021-09-01)

http://www.rjor.ro/possibilities-of-homeopathic-treatment-of-recurrent-oral-aphthae/
by: Sorana Maria Bucur, et al.
Published: (2021-03-01)

Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature review
by: Jessica D. Rich, et al.
Published: (2019-10-01)

Effect of Oral Cryotherapy on Combination Chemotherapy-induced Oral Mucositis: A Randomized Clinical Trial
by: Abbas Heydari, et al.
Published: (2012-04-01)

Differential B-Cell Receptor Signaling Requirement for Adhesion of Mantle Cell Lymphoma Cells to Stromal Cells
by: Laia Sadeghi, et al.
Published: (2020-05-01)

The Effect of Topical Sucralfate Suspension on Oral Aphthae
by: Z. Delavarian, et al.
Published: (2007-06-01)

Is it herpes or aphthae lesions?
by: Irna Sufiawati, et al.
Published: (2008-03-01)

Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date
by: Sawalha Y, et al.
Published: (2020-07-01)

The Effect of Aloe Vera Solution on Chemotherapy-Induced Stomatitis in Clients with Lymphoma and Leukemia: A Randomized Controlled Clinical Trial
by: Parisa Mansouri, et al.
Published: (2016-04-01)

Petechial, purpuric, and ecchymotic presentation of cutaneous Cryptococcus in mantle cell lymphoma
by: Christie D. Kimball, BS, et al.
Published: (2017-01-01)

Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date [Corrigendum]
by: Sawalha Y, et al.
Published: (2020-09-01)

Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib
by: Denlinger NM, et al.
Published: (2018-03-01)

Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma
by: Fouad Choueiry, et al.
Published: (2021-04-01)

Distal chromosome 1q aberrations and initial response to ibrutinib in central nervous system relapsed mantle cell lymphoma
by: Marcus Høy Hansen, et al.
Published: (2021-01-01)

Management of mantle cell lymphoma in the elderly patient
by: Doorduijn JK, et al.
Published: (2013-09-01)

Macrophage-Mediated Antibody Dependent Effector Function in Aggressive B-Cell Lymphoma Treatment is Enhanced by Ibrutinib via Inhibition of JAK2
by: Verena Barbarino, et al.
Published: (2020-08-01)

Targeting Bruton Tyrosine Kinase: A novel strategy in the treatment of B-cell lymphomas
by: Sklavenitis-Pistofidis R., et al.
Published: (2017-06-01)

Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation
by: Brendan P. Hodkinson, et al.
Published: (2021-01-01)

Excellent outcome of immunomodulation or Bruton’s tyrosine kinase inhibition in highly refractory primary cutaneous diffuse large B-cell lymphoma, leg type
by: Eva Gupta, et al.
Published: (2015-12-01)

Prevalence of recurrent aphthous stomatitis in western population of Maharashtra, India
by: Yojari R Rajmane, et al.
Published: (2017-01-01)

Dynamic Changes in Gene Mutational Landscape With Preservation of Core Mutations in Mantle Cell Lymphoma Cells
by: Qian Zhang, et al.
Published: (2019-07-01)

The diagnosis and treatment of primary vitreoretinal lymphoma: a review
by: Jose S. Pulido, et al.
Published: (2018-05-01)

Safety and efficacy of ibrutinib in a patient with severe renal impairment
by: Kalman Filanovsky, et al.
Published: (2017-09-01)

Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation
by: Francesca Maria Quaglia, et al.
Published: (2019-08-01)

Multifocal periungual granulation tissue related to ibrutinib therapy
by: Aatman Shah, MD, et al.
Published: (2020-02-01)

Rapid Improvement of Genital Aphthae by Topical FK-506 in
by: Mansoor Karimifar, et al.
Published: (2011-03-01)